1 Min Read
Feb 1 (Reuters) - Tetra Bio-pharma Inc :
* Tetra Bio-Pharma Inc receives notice of authorization from Health Canada for the conduct of its clinical trial with its PPTGR topical product Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.